1Dupriez B, Morel P, Demory JL, et al. Prognostic factors in agnogenic myeloid metapltusia: a report on 195 cases with a new scoring system. Blood, 1996,88(5) : 1013-1018.
2Okamura T, Kinukawa N, Niho Y, et al. Primary chronic myelofibrosis: clinical and prognostic evaluation in 336 Japanese patients.Int J Hematol,2001,73( 1 ) : 194-198.
3Visani G, Finelli C, Castelli U, et al. Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients. Br J Haematol, 1990,75 ( 1 ) : 4-9.
5Mesa RA,Silverstein MN,Jacobsen SJ,et al.Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia:an Olmsted County Study,1976-1995[J].Am J Hematol,1999,61(1):10-15.
6Cervantes F,Pereira A,Esteve J,et al.Identification of‘short-lived’ and ‘long-lived’ patients at presentation of idiopathic myelofibrosis[J].Br J Haematol,1997,97 (3):635-640.
7Tefferi A,Huang J,Schwager S,et al.Validation and comparison of contemporary prognostic models in primary myelofibrosis:analysis based on 334 patients from a single institution[J].Cancer,2007,109(10):2083-2088.
8Cervantes F,Dupriez B,Pereira A,et al.New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment[J].Blood,2009,113(13):2895-2901.
9Passamonti F,Cervantes F.Vannucchi AM,et al.A dynamic prognostic model to predict survival in primary myelofibrosis:a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)[J].Blood,2010,115(9):1703-1708.
10Xu ZF,Gale RP,Zhang Y,et al.Unique features of primary myelofibrosis in Chinese[J].Blood,2012,119(11):2469-2473.
